In a filing, Puma Biotechnology Inc revealed its Chief Financial Officer NOUGUES MAXIMO F unloaded Company’s shares for reported $32232.0 on Jan 02 ’25. In the deal valued at $3.15 per share,10,227 shares were sold. As a result of this transaction, NOUGUES MAXIMO F now holds 152,295 shares worth roughly $0.5 million.
Then, Ludwig Jeffrey Jerome sold 9,437 shares, generating $29,743 in total proceeds. Upon selling the shares at $3.15, the Chief Commercial Officer now owns 108,951 shares.
Before that, HUNT DOUGLAS M sold 8,633 shares. Puma Biotechnology Inc shares valued at $27,209 were divested by the insider at a price of $3.15 per share. As a result of the transaction, HUNT DOUGLAS M now holds 124,594 shares, worth roughly $0.41 million.
Citigroup upgraded its Puma Biotechnology Inc [PBYI] rating to a Buy from a a Neutral in a research note published recently. Goldman also remained covering PBYI and has decreased its forecast on October 08, 2019 with a “Sell” recommendation from previously “Neutral” rating. Citigroup revised its rating on May 10, 2019. It rated PBYI as “a Neutral” which previously was an “a Buy”.
Price Performance Review of PBYI
On Friday, Puma Biotechnology Inc [NASDAQ:PBYI] saw its stock fall -6.76% to $3.31. Over the last five days, the stock has gained 6.09%. Puma Biotechnology Inc shares have risen nearly 8.52% since the year began. Nevertheless, the stocks have fallen -30.75% over the past one year. While a 52-week high of $7.73 was reached on 01/07/25, a 52-week low of $2.22 was recorded on 01/03/25. SMA at 50 days reached $3.03, while 200 days put it at $3.47.
Levels Of Support And Resistance For PBYI Stock
The 24-hour chart illustrates a support level at 3.21, which if violated will result in even more drops to 3.10. On the upside, there is a resistance level at 3.51. A further resistance level may holdings at 3.70. The Relative Strength Index (RSI) on the 14-day chart is 54.74, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.39, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 55.97%. Stochastics %K at 55.97% indicates the stock is a holding.
How much short interest is there in Puma Biotechnology Inc?
A steep rise in short interest was recorded in Puma Biotechnology Inc stocks on 2024-12-13, dropping by 77303.0 shares to a total of 2.91 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 2.98 million shares. There was a decline of -2.66%, which implies that there is a negative sentiment for the stock.
